PROTHENA CORPORATION PUBLIC LIMITED COMPANY Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 268.10 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 243.01K shares, a 426.08% increase year-over-year.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 25.09K shares, a 39.96% decline year-over-year.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 78.39K shares, a 45.73% increase year-over-year.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 1.24M shares, a 352.16% increase year-over-year.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 1.41M shares, a 168.81% increase from fiscal 2024.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 524.50K shares, a 113.16% increase from fiscal 2023.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 246.06K shares, a 6.21% increase from fiscal 2022.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 231.67K shares, a 54.86% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 243.01K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 268.10K shares 10-Q · filed 2026-08-06 | 346.49K shares derived: sum of 3 quarters · filed 2026-08-06 | 1.59M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 25.09K shares 10-Q · filed 2026-05-07 | 103.48K shares derived: sum of 2 quarters · filed 2026-05-07 | 1.35M shares derived: sum of 3 quarters · filed 2026-05-07 | 1.39M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 78.39K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 1.32M shares derived: sum of 2 quarters · filed 2026-02-27 | 1.37M shares derived: sum of 3 quarters · filed 2026-02-27 | 1.41M shares 10-K · filed 2026-02-27 |
| 2025-09-30 | 1.24M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 1.29M shares derived: sum of 2 quarters · filed 2025-11-06 | 1.33M shares 10-Q · filed 2025-11-06 | 1.39M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 46.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 87.99K shares 10-Q · filed 2025-08-04 | 141.77K shares derived: sum of 3 quarters · filed 2025-08-04 | 416.79K shares derived: sum of 4 quarters · filed 2025-08-04 |
| 2025-03-31 | 41.80K shares 10-Q · filed 2025-05-08 | 95.58K shares derived: sum of 2 quarters · filed 2025-05-08 | 370.60K shares derived: sum of 3 quarters · filed 2025-05-08 | 500.51K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 53.79K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 328.81K shares derived: sum of 2 quarters · filed 2025-02-27 | 458.71K shares derived: sum of 3 quarters · filed 2025-02-27 | 524.50K shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 275.02K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 404.93K shares derived: sum of 2 quarters · filed 2024-11-12 | 470.72K shares 10-Q · filed 2024-11-12 | 541.81K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 129.91K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 195.70K shares 10-Q · filed 2024-08-08 | 266.79K shares derived: sum of 3 quarters · filed 2024-08-08 | 356.14K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 65.79K shares 10-Q · filed 2024-05-08 | 136.88K shares derived: sum of 2 quarters · filed 2024-05-08 | 226.24K shares derived: sum of 3 quarters · filed 2024-05-08 | 240.93K shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 71.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 160.44K shares derived: sum of 2 quarters · filed 2024-02-22 | 175.14K shares derived: sum of 3 quarters · filed 2024-02-22 | 246.06K shares 10-K · filed 2024-02-22 |
| 2023-09-30 | 89.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 104.05K shares derived: sum of 2 quarters · filed 2023-11-02 | 174.98K shares 10-Q · filed 2023-11-02 | 232.74K shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-06-30 | 14.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 85.62K shares 10-Q · filed 2023-08-03 | 143.38K shares derived: sum of 3 quarters · filed 2023-08-03 | 294.16K shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 70.93K shares 10-Q · filed 2023-05-04 | 128.69K shares derived: sum of 2 quarters · filed 2023-05-04 | 279.46K shares derived: sum of 3 quarters · filed 2023-05-04 | 284.34K shares derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | 57.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 208.54K shares derived: sum of 2 quarters · filed 2023-02-28 | 213.41K shares derived: sum of 3 quarters · filed 2023-02-28 | 231.67K shares 10-K · filed 2023-02-28 |
| 2022-09-30 | 150.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 155.65K shares derived: sum of 2 quarters · filed 2022-11-03 | 173.91K shares 10-Q · filed 2022-11-03 | 219.44K shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 4.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 23.14K shares 10-Q · filed 2022-08-08 | 68.67K shares derived: sum of 3 quarters · filed 2022-08-08 | 116.85K shares derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | 18.26K shares 10-Q · filed 2022-05-05 | 63.79K shares derived: sum of 2 quarters · filed 2022-05-05 | 111.98K shares derived: sum of 3 quarters · filed 2022-05-05 | 294.61K shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 45.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | 93.72K shares derived: sum of 2 quarters · filed 2022-02-25 | 276.35K shares derived: sum of 3 quarters · filed 2022-02-25 | 513.23K shares 10-K · filed 2022-02-25 |
| 2021-09-30 | 48.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 230.82K shares derived: sum of 2 quarters · filed 2021-11-04 | 467.70K shares 10-Q · filed 2021-11-04 | 487.31K shares derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | 182.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 419.51K shares 10-Q · filed 2021-08-05 | 439.12K shares derived: sum of 3 quarters · filed 2021-08-05 | 453.09K shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | 236.88K shares 10-Q · filed 2021-05-11 | 256.48K shares derived: sum of 2 quarters · filed 2021-05-11 | 270.46K shares derived: sum of 3 quarters · filed 2021-05-11 | 270.46K shares derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-12-31 | 19.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | 33.58K shares derived: sum of 2 quarters · filed 2021-02-26 | 33.58K shares derived: sum of 3 quarters · filed 2021-02-26 | 54.54K shares 10-K · filed 2021-02-26 |
| 2020-09-30 | 13.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | 13.97K shares derived: sum of 2 quarters · filed 2020-11-04 | 34.94K shares 10-Q · filed 2020-11-04 | -255.21K shares derived: sum of 4 quarters · filed 2020-11-04 |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 20.96K shares 10-Q · filed 2020-08-06 | -269.19K shares derived: sum of 3 quarters · filed 2020-08-06 | 6.80K shares derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | 20.96K shares 10-Q · filed 2020-05-06 | -269.19K shares derived: sum of 2 quarters · filed 2020-05-06 | 6.80K shares derived: sum of 3 quarters · filed 2020-05-06 | 204.38K shares derived: sum of 4 quarters · filed 2020-05-06 |
| 2019-12-31 | -290.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -14.16K shares derived: sum of 2 quarters · filed 2020-03-03 | 183.42K shares derived: sum of 3 quarters · filed 2020-03-03 | 509.21K shares 10-K · filed 2020-03-03 |
| 2019-09-30 | 275.98K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 473.57K shares derived: sum of 2 quarters · filed 2019-11-05 | 799.36K shares 10-Q · filed 2019-11-05 | 1.42M shares derived: sum of 4 quarters · filed 2019-11-05 |
| 2019-06-30 | 197.58K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 523.38K shares 10-Q · filed 2019-08-06 | 1.14M shares derived: sum of 3 quarters · filed 2019-08-06 | 1.58M shares derived: sum of 4 quarters · filed 2019-08-06 |
| 2019-03-31 | 325.79K shares 10-Q · filed 2019-05-07 | 946.18K shares derived: sum of 2 quarters · filed 2019-05-07 | 1.38M shares derived: sum of 3 quarters · filed 2019-05-07 | |
| 2018-12-31 | 620.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | 1.06M shares derived: sum of 2 quarters · filed 2019-03-15 | 1.61M shares 10-K · filed 2019-03-15 | |
| 2018-09-30 | 434.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 994.04K shares 10-Q · filed 2018-11-06 | ||
| 2018-06-30 | 559.09K shares 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |